121 related articles for article (PubMed ID: 24471753)
21. Sialic acid acts as a receptor for equine rhinitis A virus binding and infection.
Stevenson RA; Huang JA; Studdert MJ; Hartley CA
J Gen Virol; 2004 Sep; 85(Pt 9):2535-2543. PubMed ID: 15302947
[TBL] [Abstract][Full Text] [Related]
22. Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with EIV A/eq2/Richmond/1/07.
Paillot R; Prowse L; Montesso F; Stewart B; Jordon L; Newton JR; Gilkerson JR
Vet Microbiol; 2013 Sep; 166(1-2):22-34. PubMed ID: 23769636
[TBL] [Abstract][Full Text] [Related]
23. Equine rhinitis A virus-like particle expressing DNA vaccine induces a virus neutralising immune response in mice.
Lynch SE; Gilkerson JR; Symes SJ; Huang JA; Tatarczuch L; Hartley CA
Virus Res; 2011 Jun; 158(1-2):294-7. PubMed ID: 21539868
[TBL] [Abstract][Full Text] [Related]
24. Abortions in dromedaries (Camelus dromedarius) caused by equine rhinitis A virus.
Wernery U; Knowles NJ; Hamblin C; Wernery R; Joseph S; Kinne J; Nagy P
J Gen Virol; 2008 Mar; 89(Pt 3):660-666. PubMed ID: 18272756
[TBL] [Abstract][Full Text] [Related]
25. Pathogenicity of a Venezuelan equine encephalomyelitis serotype IE virus isolate for ponies.
Sahu SP; Pedersen DD; Jenny AL; Schmitt BJ; Alstad AD
Am J Trop Med Hyg; 2003 Apr; 68(4):485-94. PubMed ID: 12875302
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence study of Equine rhinitis B virus (ERBV) in Australian weanling horses using serotype-specific ERBV enzyme-linked immunosorbent assays.
Horsington J; Hartley CA; Gilkerson JR
J Vet Diagn Invest; 2013 Sep; 25(5):641-4. PubMed ID: 23960171
[TBL] [Abstract][Full Text] [Related]
27. Equine rhinitis A virus: structural proteins and immune response.
Hartley CA; Ficorilli N; Dynon K; Drummer HE; Huang JA; Studdert MJ
J Gen Virol; 2001 Jul; 82(Pt 7):1725-1728. PubMed ID: 11413384
[TBL] [Abstract][Full Text] [Related]
28. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
Breathnach CC; Yeargan MR; Timoney JF; Allen GP
Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
[TBL] [Abstract][Full Text] [Related]
29. Viral, Serological, and Antioxidant Investigations of Equine Rhinitis A Virus in Serum and Nasal Swabs of Commercially Used Horses in Poland.
Bażanów B; Frącka A; Jackulak N; Romuk E; Gębarowski T; Owczarek A; Stygar D
Biomed Res Int; 2018; 2018():8719281. PubMed ID: 29850583
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of orally administered valacyclovir in experimentally EHV1-infected ponies.
Garré B; Gryspeerdt A; Croubels S; De Backer P; Nauwynck H
Vet Microbiol; 2009 Mar; 135(3-4):214-21. PubMed ID: 18986780
[TBL] [Abstract][Full Text] [Related]
31. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
32. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
33. Development of one-step TaqMan® real-time reverse transcription-PCR and conventional reverse transcription-PCR assays for the detection of equine rhinitis A and B viruses.
Lu Z; Timoney PJ; White J; Balasuriya UB
BMC Vet Res; 2012 Jul; 8():120. PubMed ID: 22830930
[TBL] [Abstract][Full Text] [Related]
34. Clinical and virological outcome of an infection with the Belgian equine arteritis virus strain 08P178.
Vairo S; Vandekerckhove A; Steukers L; Glorieux S; Van den Broeck W; Nauwynck H
Vet Microbiol; 2012 Jun; 157(3-4):333-44. PubMed ID: 22306037
[TBL] [Abstract][Full Text] [Related]
35. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
36. A survey of respiratory viruses in New Zealand horses.
McBrearty KA; Murray A; Dunowska M
N Z Vet J; 2013 Sep; 61(5):254-61. PubMed ID: 23425354
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of bovine herpesvirus 1247 and equine herpesvirus 1 in ponies.
Crandell RA; Drysdale S; Stein TL
Can J Comp Med; 1979 Jan; 43(1):94-7. PubMed ID: 218710
[TBL] [Abstract][Full Text] [Related]
38. Denatured virion protein 1 of equine rhinitis B virus 1 contains authentic B-cell epitopes recognised in an enzyme-linked immunosorbent assay--short communication.
Kriegshäuser G; Cullinane A; Kuechler E; Skern T
Acta Vet Hung; 2008 Jun; 56(2):265-70. PubMed ID: 18669254
[TBL] [Abstract][Full Text] [Related]
39. Differences in replication kinetics and cell tropism between neurovirulent and non-neurovirulent EHV1 strains during the acute phase of infection in horses.
Gryspeerdt AC; Vandekerckhove AP; Garré B; Barbé F; Van de Walle GR; Nauwynck HJ
Vet Microbiol; 2010 May; 142(3-4):242-53. PubMed ID: 19926232
[TBL] [Abstract][Full Text] [Related]
40. Reverse transcriptase-polymerase chain reaction for the detection equine rhinitis B viruses and cell culture isolation of the virus.
Black WD; Hartley CA; Ficorilli NP; Studdert MJ
Arch Virol; 2007 Jan; 152(1):137-49. PubMed ID: 16932985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
